This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
On October 17, 2018, Canada nationally legalized medical and recreational cannabis use for adults. In doing so, that country has set the stage for significant R&D of legal cannabis edibles and beverages—often with the help of U.S. investors.
Canada will also attract significant attention from American cannabis industry pioneers, regulators and others as the U.S. considers its path in the wake of ongoing state-by-state legalization—and the associated regulatory underpinnings.